Ironwood Pharmaceuticals (IRWD) PT Lowered to $17 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St set to open higher as oil slips; telecoms hit by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $3.87 --0%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 28
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 28
Join SI Premium – FREE
BTIG analyst Timothy Chiang lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $17.00 (from $21.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Alignment Healthcare Inc (ALHC) to Neutral
- Sherwin-Williams (SHW) PT Lowered to $410 at Goldman Sachs
- LG Household & Health Care Ltd (0519000:KS) (LGHHF) PT Lowered to KRW262,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
